| 1292 |
Truenat MTB Assay Results Interpretation: Visualization |
04/06/2024 |
Laboratory services and management |
| 1293 |
TrueNAT MTB Assay Results Interpretation: Detection of Mycobacterium tuberculosis and RIF Resistance |
04/06/2024 |
Laboratory services and management |
| 1294 |
TrueNAT MTB Assay Results Interpretation - Indeterminate |
04/06/2024 |
Laboratory services and management |
| 1296 |
Maintenance of the Truenat Instrument - General Principles |
04/06/2024 |
Laboratory services and management |
| 1298 |
External Quality Assurance of TrueNAT |
04/06/2024 |
Laboratory services and management |
| 1303 |
Visualization of CBNAAT Test Results |
04/06/2024 |
Laboratory services and management |
| 1305 |
Troubleshooting Process for CBNAAT |
04/06/2024 |
Laboratory services and management |
| 1311 |
Maintenance of CBNAAT Instrument under NTEP |
04/06/2024 |
Laboratory services and management |
| 1314 |
Monitoring of CBNAAT Quality Indicators |
04/06/2024 |
Laboratory services and management |
| 1317 |
Universal Drug-susceptibility Testing (UDST) for TB |
04/06/2024 |
Laboratory services and management |
| 1318 |
Diagnostic Tools Used in Non-tuberculous Mycobacterial [NTM] Infection |
04/06/2024 |
Laboratory services and management |
| 1331 |
Personal Protective Equipment [PPE] Use in TB Lab Settings |
04/06/2024 |
Laboratory services and management |
| 1338 |
Exposure to Tuberculosis Bacilli and risk of infection |
04/06/2024 |
Laboratory services and management |
| 1350 |
Fluorescence Microscopy |
04/06/2024 |
Laboratory services and management |
| 1354 |
Inbuilt Controls of CBNAAT Technology |
04/06/2024 |
Laboratory services and management |
| 1359 |
WHO Recommended SOPs for Xpert MTB/RIF Sample Processing |
04/06/2024 |
Laboratory services and management |
| 1361 |
Indications for retesting in CBNAAT |
04/06/2024 |
Laboratory services and management |
| 1363 |
Storage of Slides for QA |
04/06/2024 |
Laboratory services and management |
| 1364 |
Preparation of Reagents for FM Microscopy |
04/06/2024 |
Laboratory services and management |
| 1367 |
PCR Amplification of the Target genes in Truenat |
04/06/2024 |
Laboratory services and management |
| 1371 |
Interfering Substances causing errors in NAAT Assay |
04/06/2024 |
Laboratory services and management |
| 1375 |
Specimen Preparation for LC and LPA Labs |
04/06/2024 |
Laboratory services and management |
| 1377 |
Challenges in Laboratory Systems and Diagnosis |
04/06/2024 |
Laboratory services and management |
| 1380 |
Truenat Instrument Installation Criteria |
04/06/2024 |
Laboratory services and management |
| 1397 |
External Quality Assurance [EQA] for Microscopy |
04/06/2024 |
Laboratory services and management |
| 1416 |
Polymerase Chain Reaction (PCR) Technology for M.TB |
04/06/2024 |
Laboratory services and management |
| 1422 |
Dosing of Medicines Used in Second-line MDR-TB Regimens by Weight Band in Patients Under 15 Years |
04/06/2024 |
Laboratory services and management |
| 1427 |
Medication Event Reminder Monitor [MERM] Boxes |
04/06/2024 |
Laboratory services and management |
| 1568 |
Management of M/XDR-TB Treatment During Pregnancy |
04/06/2024 |
Laboratory services and management |
| 1569 |
Counselling during DR-TB treatment |
04/06/2024 |
Laboratory services and management |
